PPP3R2
gene geneOn this page
Also known as PPP3RL
Summary
PPP3R2 (protein phosphatase 3 regulatory subunit B, beta, HGNC:9318) is a protein-coding gene on chromosome 9q31.1, encoding Calcineurin subunit B type 2 (Q96LZ3). Regulatory subunit of calcineurin, a calcium-dependent, calmodulin stimulated protein phosphatase.
Enables calcium-dependent protein serine/threonine phosphatase regulator activity. Predicted to be involved in calcineurin-mediated signaling. Predicted to act upstream of or within penetration of zona pellucida. Predicted to be located in cytosol. Predicted to be part of calcineurin complex.
Source: NCBI Gene 5535 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 2 total
- MANE Select transcript:
NM_147180
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:9318 |
| Approved symbol | PPP3R2 |
| Name | protein phosphatase 3 regulatory subunit B, beta |
| Location | 9q31.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | PPP3RL |
| Ensembl gene | ENSG00000188386 |
| Ensembl biotype | protein_coding |
| OMIM | 613821 |
| Entrez | 5535 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000374806, ENST00000636434
RefSeq mRNA: 1 — MANE Select: NM_147180
NM_147180
CCDS: CCDS6759
Canonical transcript exons
ENST00000374806 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001464705 | 101591604 | 101594969 |
Expression profiles
Bgee: expression breadth broad, 28 present calls, max score 96.54.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3280 / max 279.6727, expressed in 6 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 101762 | 0.2897 | 4 |
| 101763 | 0.0316 | 4 |
| 101764 | 0.0067 | 3 |
Top tissues by expression
205 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adult organism | UBERON:0007023 | 96.54 | gold quality |
| sperm | CL:0000019 | 95.64 | gold quality |
| left testis | UBERON:0004533 | 95.03 | gold quality |
| right testis | UBERON:0004534 | 94.06 | gold quality |
| testis | UBERON:0000473 | 92.30 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.95 | gold quality |
| tibialis anterior | UBERON:0001385 | 70.89 | silver quality |
| pancreatic ductal cell | CL:0002079 | 66.92 | silver quality |
| ileal mucosa | UBERON:0000331 | 62.64 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 55.49 | gold quality |
| cerebellar vermis | UBERON:0004720 | 54.58 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| myocardium | UBERON:0002349 | 50.25 | gold quality |
| quadriceps femoris | UBERON:0001377 | 48.80 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.03 | gold quality |
| skin of hip | UBERON:0001554 | 46.85 | silver quality |
| vastus lateralis | UBERON:0001379 | 45.49 | gold quality |
| thymus | UBERON:0002370 | 45.09 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 43.86 | gold quality |
| layer of synovial tissue | UBERON:0007616 | 43.55 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| right coronary artery | UBERON:0001625 | 42.72 | silver quality |
| sural nerve | UBERON:0015488 | 42.72 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| gastrocnemius | UBERON:0001388 | 42.36 | gold quality |
| muscle of leg | UBERON:0001383 | 42.23 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.13 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
114 targeting PPP3R2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-450A-1-3P | 100.00 | 69.33 | 1837 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-574-5P | 100.00 | 66.01 | 989 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-3605-5P | 99.96 | 67.12 | 932 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-6772-5P | 99.94 | 67.01 | 577 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-8062 | 99.88 | 68.43 | 995 |
Literature-anchored findings (GeneRIF, showing 6)
- PPP3RL gene localizes to human chromosome 9q22 and transcripts of PPP3RL gene are specifically expressed in the testis. (PMID:15865209)
- cyclosporin and tacrolimus exert significantly different effects on calcineurin activity in renal transplant patients with stable, well-functioning grafts (PMID:16961774)
- calcineurin B potentiates the activation of procaspase-3 by accelerating its proteolytic maturation (PMID:17324936)
- Here, we report that Cabin1 has additional CN binding domain in its 701-900 amino acid residues. (PMID:17531200)
- Data suggest that calcineurin may regulate the kinase activity of CDK4 in a cell cycle-dependent manner and may be an important component of the negative regulation of CDK4. (PMID:17892862)
- Data suggest an association between polymorphisms in PPP3CA, PPP3R1 and PPP3R2 and baseline levels or trainability of endurance phenotype traits. (PMID:20107831)
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ppp3r2 | ENSMUSG00000028310 |
| rattus_norvegicus | Ppp3r2 | ENSRNOG00000074514 |
| drosophila_melanogaster | CG32812 | FBGN0025642 |
| drosophila_melanogaster | Cib2 | FBGN0034558 |
| drosophila_melanogaster | elm | FBGN0037358 |
| drosophila_melanogaster | CG14362 | FBGN0038186 |
| caenorhabditis_elegans | calm-1 | WBGENE00009260 |
| caenorhabditis_elegans | WBGENE00014109 | |
| caenorhabditis_elegans | WBGENE00019108 |
Paralogs (8): TESC (ENSG00000088992), CIB2 (ENSG00000136425), CIB3 (ENSG00000141977), CIB4 (ENSG00000157884), CHP2 (ENSG00000166869), CIB1 (ENSG00000185043), CHP1 (ENSG00000187446), PPP3R1 (ENSG00000221823)
Protein
Protein identifiers
Calcineurin subunit B type 2 — Q96LZ3 (reviewed: Q96LZ3)
Alternative names: Calcineurin B-like protein, Calcineurin BII, PPP3R1-like, Protein phosphatase 2B regulatory subunit 2, Protein phosphatase 3 regulatory subunit B beta isoform
All UniProt accessions (2): A0A1B0GUC7, Q96LZ3
UniProt curated annotations — full annotation on UniProt →
Function. Regulatory subunit of calcineurin, a calcium-dependent, calmodulin stimulated protein phosphatase. Confers calcium sensitivity.
Subunit / interactions. Forms a complex composed of a calmodulin-dependent catalytic subunit (also known as calcineurin A) and a regulatory Ca(2+)-binding subunit (also known as calcineurin B). There are three catalytic subunits, each encoded by a separate gene (PPP3CA, PPP3CB, and PPP3CC) and two regulatory subunits which are also encoded by separate genes (PPP3R1 and PPP3R2). Interacts with SPATA33 (via PQIIIT motif).
Subcellular location. Mitochondrion.
Tissue specificity. Testis-specific.
Miscellaneous. This protein has four functional calcium-binding sites.
Similarity. Belongs to the calcineurin regulatory subunit family.
RefSeq proteins (1): NP_671709* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002048 | EF_hand_dom | Domain |
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR018247 | EF_Hand_1_Ca_BS | Binding_site |
Pfam: PF13499
Enzyme classification (BRENDA):
- EC 3.1.3.16 — protein-serine/threonine phosphatase (BRENDA: 92 organisms, 641 substrates, 468 inhibitors, 127 Km, 67 kcat entries)
Substrate kinetics (BRENDA)
59 substrates with measured Km, best-characterized 15. Km ranges are aggregated across organisms/conditions.
| Substrate | Km (mM) | Measurements |
|---|---|---|
| 6,8-DIFLUORO-4-METHYLUMBELLIFERYL PHOSPHATE | 0.023–0.862 | 22 |
| 4-NITROPHENYL PHOSPHATE | 0.0028–12.7 | 13 |
| P-NITROPHENYL PHOSPHATE | 3–200 | 11 |
| RRAPTVA | 0.058–1.954 | 4 |
| PHOSPHOCASEIN | 0.0001–0.002 | 3 |
| PHOSPHOHISTONE | 0.0023–0.0723 | 3 |
| PHOSPHORYLATED MYOSIN LIGHT CHAIN PEPTIDE | 0.01–0.11 | 3 |
| PHOSPHOSERINE-MYELIN BASIC PROTEIN | 0.0004–0.022 | 3 |
| DLDVPIPGRFDRRVSVAAE | 0.0006–0.0138 | 2 |
| DLDVPIPGRFDRRVY(P)VAAE | 0.0025–0.023 | 2 |
| PHOSPHORYLASE A | 0.004–0.021 | 2 |
| RRA(PT)VA | 0.0536–0.308 | 2 |
| 80S-RIBOSOME | 0.0027 | 1 |
| AAAPTVA | 0.206 | 1 |
| AGPALSPVPPV | 0.357 | 1 |
UniProt features (31 total): binding site 20, domain 4, site 2, initiator methionine 1, chain 1, lipid moiety-binding region 1, sequence conflict 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96LZ3-F1 | 91.96 | 0.77 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (2): 118 (interaction with pxvp motif in substrates of the catalytic subunit); 122 (interaction with pxvp motif in substrates of the catalytic subunit)
Ligand- & substrate-binding residues (20): 37; 42; 63; 65; 67; 69; 74; 100; 102; 104; 106; 111 …
Post-translational modifications (1): 2
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 136 (showing top):
GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT, GOBP_SINGLE_FERTILIZATION, GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT, GOBP_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING, KEGG_MAPK_SIGNALING_PATHWAY, GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING, GOBP_NEGATIVE_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_CALCIUM_ION_IMPORT, GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT, GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT, GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_REGULATION_OF_CALCIUM_ION_IMPORT
GO Biological Process (5): penetration of zona pellucida (GO:0007341), positive regulation of calcineurin-NFAT signaling cascade (GO:0070886), calcineurin-mediated signaling (GO:0097720), positive regulation of calcium ion import across plasma membrane (GO:1905665), negative regulation of calcium ion import across plasma membrane (GO:1905949)
GO Molecular Function (5): calcium ion binding (GO:0005509), calcium-dependent protein serine/threonine phosphatase regulator activity (GO:0008597), phosphatase binding (GO:0019902), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (7): mitochondrion (GO:0005739), cytosol (GO:0005829), calcineurin complex (GO:0005955), protein serine/threonine phosphatase complex (GO:0008287), sperm mitochondrial sheath (GO:0097226), sperm flagellum (GO:0036126), sperm midpiece (GO:0097225)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| calcium ion import across plasma membrane | 2 |
| regulation of calcium ion import across plasma membrane | 2 |
| cytoplasm | 2 |
| single fertilization | 1 |
| multi-multicellular organism process | 1 |
| multicellular organismal reproductive process | 1 |
| calcineurin-NFAT signaling cascade | 1 |
| regulation of calcineurin-NFAT signaling cascade | 1 |
| positive regulation of calcineurin-mediated signaling | 1 |
| calcium-mediated signaling | 1 |
| positive regulation of calcium ion import | 1 |
| positive regulation of calcium ion transmembrane transport | 1 |
| negative regulation of calcium ion import | 1 |
| negative regulation of calcium ion transmembrane transport | 1 |
| metal ion binding | 1 |
| calcium-dependent protein serine/threonine phosphatase activity | 1 |
| protein phosphatase regulator activity | 1 |
| enzyme binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| protein serine/threonine phosphatase complex | 1 |
| intracellular protein-containing complex | 1 |
| phosphatase complex | 1 |
| sperm midpiece | 1 |
| 9+2 motile cilium | 1 |
| sperm flagellum | 1 |
Protein interactions and networks
STRING
1719 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PPP3R2 | PPP3CC | P48454 | 795 |
| PPP3R2 | PPP3CB | P16298 | 739 |
| PPP3R2 | PPP3CA | Q08209 | 685 |
| PPP3R2 | SOS2 | Q07890 | 577 |
| PPP3R2 | CALML6 | Q8TD86 | 496 |
| PPP3R2 | CALML4 | Q96GE6 | 496 |
| PPP3R2 | SNRK | Q9NRH2 | 479 |
| PPP3R2 | ZBTB25 | P24278 | 433 |
| PPP3R2 | STK25 | O00506 | 431 |
| PPP3R2 | STK11 | Q15831 | 391 |
| PPP3R2 | AURKA | O14965 | 383 |
| PPP3R2 | PPP3R1 | P06705 | 376 |
| PPP3R2 | PIK3C2A | O00443 | 352 |
| PPP3R2 | SFRP4 | Q6FHJ7 | 348 |
| PPP3R2 | ZNF346 | Q9UL40 | 326 |
IntAct
20 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| VPS25 | VPS36 | psi-mi:“MI:0914”(association) | 0.800 |
| TFCP2 | PPP3R2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CD14 | PPP3R2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPP3R2 | APC | psi-mi:“MI:0915”(physical association) | 0.370 |
| AURKA | PPP3R2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPP3R2 | BUB1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPP3R2 | CCND1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| DLC1 | PPP3R2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPP3R2 | FBXW7 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MLH3 | PPP3R2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MSH2 | PPP3R2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPP3R2 | PDGFRL | psi-mi:“MI:0915”(physical association) | 0.370 |
| PTPN12 | PPP3R2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PTPRJ | PPP3R2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| SMAD4 | PPP3R2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPP3R2 | ANKRD33B | psi-mi:“MI:0914”(association) | 0.350 |
| PPP3R2 | MAP2K7 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (32): TFCP2 (Two-hybrid), PPP3R2 (Two-hybrid), PPP3R2 (Two-hybrid), PPP3R2 (Two-hybrid), PPP3R2 (Two-hybrid), PPP3R2 (Two-hybrid), PPP3R2 (Two-hybrid), PPP3R2 (Two-hybrid), PPP3R2 (Two-hybrid), PPP3R2 (Two-hybrid), PPP3R2 (Two-hybrid), PPP3R2 (Two-hybrid), PPP3R2 (Two-hybrid), PPP3R2 (Two-hybrid), PPP3R2 (Two-hybrid)
ESM2 similar proteins: G5EDN6, O73761, P0CM54, P0CM55, P21457, P22728, P25296, P28470, P29104, P34057, P35243, P35332, P42322, P43080, P43081, P46065, P48451, P61022, P61023, P62760, P62761, P62762, P62763, P62764, P63098, P63099, P63100, P79880, P87072, Q24214, Q2TBI5, Q4R5F7, Q54MF3, Q55G87, Q5R6S5, Q5R7F0, Q5RD22, Q63810, Q63811, Q6BWS8
Diamond homologs: A0A2I0BVG8, A6H742, A7E3Q8, O23184, O50064, O59945, O88818, P13796, P13797, P19179, P28470, P32599, P48451, P54680, P62343, P62344, P87072, Q0DJ94, Q14651, Q24214, Q25088, Q338P8, Q3E9C0, Q3V0K9, Q61233, Q63598, Q63811, Q6DG81, Q6P698, Q6Z2M9, Q7F0J0, Q7G188, Q7XHW4, Q84UL5, Q8C5W0, Q96LZ3, Q99K51, Q9FI19, Q9FJ70, Q9FKI0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
2 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
26 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:101594310:T:TA | donor_gain | 0.9100 |
| 9:101594413:A:AC | donor_gain | 0.7900 |
| 9:101594414:C:CC | donor_gain | 0.7900 |
| 9:101594415:G:C | donor_gain | 0.7500 |
| 9:101594311:C:A | donor_gain | 0.6400 |
| 9:101594429:T:TA | donor_gain | 0.6200 |
| 9:101594417:TGAGG:T | donor_gain | 0.5200 |
| 9:101594957:C:CT | acceptor_gain | 0.5100 |
| 9:101594451:G:T | donor_gain | 0.4900 |
| 9:101594483:T:TA | donor_gain | 0.4900 |
| 9:101593331:T:TA | donor_gain | 0.4800 |
| 9:101594409:T:TA | donor_gain | 0.4800 |
| 9:101594411:A:T | donor_gain | 0.4000 |
| 9:101594949:C:CT | acceptor_gain | 0.3600 |
| 9:101594484:C:A | donor_gain | 0.3400 |
| 9:101594958:G:T | acceptor_gain | 0.3200 |
| 9:101594494:T:TA | donor_gain | 0.3100 |
| 9:101594950:A:T | acceptor_gain | 0.3100 |
| 9:101594949:C:G | acceptor_gain | 0.2600 |
| 9:101594467:T:TA | donor_gain | 0.2500 |
| 9:101594701:T:TA | donor_gain | 0.2400 |
| 9:101594590:TCCCC:T | acceptor_gain | 0.2300 |
| 9:101594168:T:TA | donor_gain | 0.2200 |
| 9:101594351:CT:C | acceptor_gain | 0.2100 |
| 9:101594352:TT:T | acceptor_gain | 0.2100 |
| 9:101594412:T:C | donor_gain | 0.2000 |
AlphaMissense
1152 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:101594634:G:C | F96L | 0.996 |
| 9:101594634:G:T | F96L | 0.996 |
| 9:101594636:A:G | F96L | 0.996 |
| 9:101594463:G:C | F153L | 0.993 |
| 9:101594463:G:T | F153L | 0.993 |
| 9:101594465:A:G | F153L | 0.993 |
| 9:101594841:A:C | F27L | 0.992 |
| 9:101594841:A:T | F27L | 0.992 |
| 9:101594843:A:G | F27L | 0.992 |
| 9:101594602:A:T | I107N | 0.991 |
| 9:101594524:A:T | V133D | 0.990 |
| 9:101594842:A:G | F27S | 0.988 |
| 9:101594635:A:G | F96S | 0.987 |
| 9:101594575:A:G | L116P | 0.986 |
| 9:101594698:A:G | F75S | 0.986 |
| 9:101594536:A:G | L129P | 0.985 |
| 9:101594602:A:C | I107S | 0.985 |
| 9:101594464:A:G | F153S | 0.984 |
| 9:101594527:A:G | L132P | 0.984 |
| 9:101594623:T:G | D100A | 0.983 |
| 9:101594587:A:G | L112P | 0.982 |
| 9:101594624:C:G | D100H | 0.982 |
| 9:101594479:A:T | I148K | 0.980 |
| 9:101594525:C:A | V133F | 0.979 |
| 9:101594636:A:T | F96I | 0.979 |
| 9:101594697:G:C | F75L | 0.978 |
| 9:101594697:G:T | F75L | 0.978 |
| 9:101594699:A:G | F75L | 0.978 |
| 9:101594602:A:G | I107T | 0.977 |
| 9:101594622:G:C | D100E | 0.977 |
dbSNP variants (sampled 300 via entrez): RS1000027248 (9:101591544 C>A), RS1000044664 (9:101595713 G>T), RS1000079271 (9:101592007 C>G,T), RS1000566431 (9:101593447 T>C), RS1000618850 (9:101593210 G>A,T), RS1002362338 (9:101593090 G>C), RS1002414761 (9:101592710 G>T), RS1003032138 (9:101595989 T>G), RS1003493574 (9:101591131 C>T), RS1003547641 (9:101591482 C>T), RS1003780109 (9:101591413 G>A), RS1004164122 (9:101593658 T>C), RS1004285448 (9:101593404 A>T), RS1004316984 (9:101592665 T>C), RS1004338148 (9:101592432 C>T)
Disease associations
OMIM: gene MIM:613821 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 2 |
| Benzo(a)pyrene | affects methylation | 1 |
| Carbamazepine | affects expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.